Lindbrook Capital, LLC Adverum Biotechnologies, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$2.08 - $3.6 $852 - $1,476	-410 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$3.36 - $10.56 $1,377 - $4,329	410 New	410 $1,000
Q4 2020 Jan 27, 2021	SELL	$9.84 - $14.26 $4,920 - $7,130	-500 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$10.3 - $21.64 $5,150 - $10,820	500 New	500 $5,000
Q4 2019 Jan 27, 2020	SELL	$5.12 - $12.22 $15,360 - $36,660	-3,000 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$5.24 - $15.89 $15,720 - $47,670	3,000 New	3,000 $16,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.